Detalhe da pesquisa
1.
Pregnancy After Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study.
JAMA
; 331(1): 49-59, 2024 01 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38059899
2.
Measuring ovarian toxicity in clinical trials: an American Society of Clinical Oncology research statement.
Lancet Oncol
; 24(10): e415-e423, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37797647
3.
Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium.
Breast Cancer Res
; 25(1): 72, 2023 06 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37340476
4.
Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival.
BMC Cancer
; 23(1): 459, 2023 May 19.
Artigo
Inglês
| MEDLINE | ID: mdl-37208678
5.
Infective complications in cancer patients treated with subcutaneous versus intravenous trastuzumab and rituximab: An individual patient data meta-analysis.
J Oncol Pharm Pract
; : 10781552231180875, 2023 Jun 16.
Artigo
Inglês
| MEDLINE | ID: mdl-37322897
6.
Survival from breast cancer in women with a BRCA2 mutation by treatment.
Br J Cancer
; 124(9): 1524-1532, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33597716
7.
Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study.
Am J Obstet Gynecol
; 225(1): 51.e1-51.e17, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33493488
8.
The value of clinical breast examination in a breast cancer surveillance program for women with germline BRCA1 or BRCA2 mutations.
Med J Aust
; 215(10): 460-464, 2021 11 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34420218
9.
Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers.
Breast Cancer Res
; 22(1): 8, 2020 01 16.
Artigo
Inglês
| MEDLINE | ID: mdl-31948486
10.
Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers.
Breast Cancer Res
; 22(1): 25, 2020 Feb 26.
Artigo
Inglês
| MEDLINE | ID: mdl-32102695
11.
The Lancet Breast Cancer Commission.
Lancet
; 403(10439): 1895-1950, 2024 May 11.
Artigo
Inglês
| MEDLINE | ID: mdl-38636533
12.
The PARP inhibitor, olaparib, depletes the ovarian reserve in mice: implications for fertility preservation.
Hum Reprod
; 35(8): 1864-1874, 2020 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32604417
13.
Prospective follow-up of quality of life for participants undergoing risk-reducing salpingo-oophorectomy or ovarian cancer screening in GOG-0199: An NRG Oncology/GOG study.
Gynecol Oncol
; 156(1): 131-139, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31759774
14.
10-year performance of four models of breast cancer risk: a validation study.
Lancet Oncol
; 20(4): 504-517, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30799262
15.
Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study.
Breast Cancer Res
; 21(1): 52, 2019 04 18.
Artigo
Inglês
| MEDLINE | ID: mdl-30999962
16.
Alcohol consumption, cigarette smoking, and familial breast cancer risk: findings from the Prospective Family Study Cohort (ProF-SC).
Breast Cancer Res
; 21(1): 128, 2019 11 28.
Artigo
Inglês
| MEDLINE | ID: mdl-31779655
17.
Benign breast disease increases breast cancer risk independent of underlying familial risk profile: Findings from a Prospective Family Study Cohort.
Int J Cancer
; 145(2): 370-379, 2019 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-30725480
18.
Age-specific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProF-SC).
Breast Cancer Res
; 20(1): 132, 2018 11 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30390716
19.
Validation of the IBIS breast cancer risk evaluator for women with lobular carcinoma in-situ.
Br J Cancer
; 119(1): 36-39, 2018 07.
Artigo
Inglês
| MEDLINE | ID: mdl-29925933
20.
Correction to: Survival from breast cancer in women with a BRCA2 mutation by treatment.
Br J Cancer
; 128(4): 703, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36639528